|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4523 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/4523 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 3370775 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16805576.2 |
| Date of filing the European patent application | 2016-11-03 | |
| (97) | Date of publication of the European application | 2018-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/060271 |
| Date | 2016-11-03 |
| (87) | Number | WO 2017/079399 |
| Date | 2017-05-11 |
| (30) | Number | Date | Country code |
| 201562250231 P | 2015-11-03 | US | |
| 201562263082 P | 2015-12-04 | US |
| (72) |
MERCHANT, Mark , US
SAMPATH, Deepak , US
KONOPLEVA, Marina Yurievna , US
HAN, Lina , US
|
| (73) |
Genentech, Inc. ,
1 DNA Way, South San Francisco, CA 94080,
US
Board of Regents, The University of Texas System , 201 West 7th Street, Austin, TX 78701, US |
| (54) | COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER |
| COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER |